Compounded medications may be used for a variety of reasons and they are an important source for otherwise unavailable medications—and for improving adherence, convenience, and affordability for patients.

Novel gene therapy treatments for inherited retinal diseases have been at the forefront of translational medicine over the past couple of decades.

In gene replacement therapy, a disease-causing gene is replaced with a functional copy of the gene.

Fibrosis in the Trabecular Meshwork (the drainage system of the eye) causes inefficient drainage of the fluid out of the eye leading to an increase in eye pressure resulting in damage to the optic nerve resulting in Glaucoma.

People with Alzheimer’s disease may gradually lose their depth perception. They may have problems distinguishing between flat pictures and three-dimensional objects or trouble judging distances.

Although both low and high estrogen levels have been associated with symptoms of dry eye disease, low androgen levels are a more consistent factor in its etiology.

Droopy eyelids, known medically as ptosis, is a condition in which the border of either one or both of the upper eyelids droops to a lower position than is normal.

Macular edema is the most common cause of vision loss in patients with uveitis. It occurs, at least in part, because proinflammatory cytokines alter the permeability of the tight junctions within either the retinal capillary endothelium.

The concept of treating glaucoma by decreasing aqueous humor production via destruction of the ciliary body dates back to the 19th century.

The maintenance of mydriasis and the control of postoperative pain and inflammation are critical to the safety and success of cataract and intraocular lens replacement surgery.